We are live on
!
Find out more
OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
5 hedge funds and large institutions have $323K invested in Oasmia Pharmaceutical AB in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
52% more capital invested
Capital invested by funds: $212K → $323K (+$111K)
25% more funds holding
Funds holding: 4 → 5 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$223K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$38.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.08K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$49K |
| 2 |
Morgan Stanley
New York
|
-$9.51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $175K | +$223K | +56,575 | New |
|
|
CLOS
2
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $107K | – | – | – |
|
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $29K | +$38.7K | +9,800 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $12K | +$5.08K | +1,286 | +47% |
|
|
VF
5
Virtu Financial
New York
| – | -$49K | -11,517 | Closed |
|
|
6
Morgan Stanley
New York
| – | -$9.51K | -2,408 | -100% |
|